PubMed Health⌕ Search

Biomedical subjects

C Poggiali

Publications and source records attributed to C Poggiali.

9 recordsLinked to original sources
PubMed1989

[Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].

Aim of our study was to evaluate the effectiveness of indobufen in the treatment of II degree stage lower limb occlusive arterial disease. Forty patients were randomly assigned to the iIndobufen (400 mg/die) treatment group or the no treatment control group (20 patients each). Doppler pressure measurement (Winsor index) and subjective symptomatology were evaluated at the time of enrollment and after one month. A significant improvement (p less than 0.01) was noted only in the treated group. We conclude that indobufen may be of therapeutic value in the treatment of peripheral occlusive arterial disease.

Aged↗
PubMed1981

[Treatment of postoperative pain with non-narcotic drugs; evaluation of lysine acetylsalicylate in high doses. Double-blind controlled study].

Further work on the treatment of postoperative pain with non-narcotic analgesics involving an investigation of the effect of twice the customary dose of lysine acetylsalicylate in a double-blind trial versus meperidine is reported. In addition to subjective and objective pain, the parameters included blood pressure, pulse rate, breathing rate, sweating, pupil diameter, nausea, vomiting, somnolence, hiccuping feeling of cold, erythema, dizziness, and nasograstric sound intolerance. Application of Wilcoxon's non-parametric tests and the chi-square test showed that the drug was as good as or better than meperidine with regard to pain, and performed very well overall with respect to the other parameters. The conclusion is drawn that its administration in high doses is justified in many patients subjected to general surgery.

Abdomen↗
PubMedDate not supplied

Evaluation of body composition during low-dose estrogen oral contraceptives treatment.

OBJECTIVE: To determine in a prospective study if the use of two low-dose estrogen oral contraceptives is associated with changes in weight or body composition. DESIGN: 80 outpatients referring to the family planning service, aged 18-43 years were randomly assigned to a treatment with the EE/desogestrel or EE/gestodene association, 20 patients with IUD, aged 26-40 years, were selected as a control group. Anthropometric data and body composition were taken at enrollment and after 6 and 12 months. MAIN OUTCOME MEASURES: Anthropometric measurements included body mass index (BMI), body composition estimated by mean of Bioelectrical Impendance Analysis (BIA). RESULTS: In the three groups weight, BMI, and total body water (TBW), and body cellular mass (BCM) remained unchanged during the study period. CONCLUSIONS: The use of EE/desogestrel and EE/gestodene is not associated with significant variations of body weight and body composition during one year treatment.

Adolescent↗